Article Details
Retrieved on: 2021-07-01 20:26:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Amgen's patent claims at issue cover a genus of monoclonal antibodies that purportedly bind to the protein PCSK9 and lower low-density lipoprotein ...
Article found on: www.jdsupra.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here